Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT01705275 Completed - Acid Reflux Clinical Trials

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Start date: January 2013
Phase: Phase 1
Study type: Interventional

A study to investigate the efficacy of ONO-8539 on acid-induced oesophageal hypersensitivity in healthy male adult volunteers.

NCT ID: NCT01705158 Completed - Ovarian Cancer Clinical Trials

Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum

MYCA
Start date: October 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy and the safety of the association of carboplatine and liposomal doxorubicin in patient with ovarian cancer in relapse, sensitive to platin.

NCT ID: NCT01704703 Completed - Clinical trials for Stage IV Colorectal Cancer

Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques

ULTRA
Start date: October 2012
Phase: Phase 2
Study type: Interventional

Open label Phase II study of FOLFIRI + Panitumumab using ultra-selection technology with next generation high sensitivity genotyping of patients with stage IV colorectal cancer refractory to irinotecan without any mutation on KRAS, PIK3Ca, BRAF and NRAS genes detected with highly sensitive techniques.

NCT ID: NCT01691560 Completed - Clinical trials for Dentine Hypersensitivity

Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

Start date: August 2012
Phase: Phase 2
Study type: Interventional

The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.

NCT ID: NCT01686022 Completed - Clinical trials for Allergy to Grass Pollen

Grass Sensitisation and Allergic Rhinitis in Thai Patients

Start date: October 2012
Phase: N/A
Study type: Observational

Allergic rhinitis patients are the patients who have nasal symptoms when triggered by indoor or outdoor allergens. Outdoor allergen can be divided into grass, tree, or weed. The type of grass or weed are different in various part of the world. The allergens from grass and weed has never been studied in Thailand. This study will find the major allergen from Bermuda grass, Johnson grass, Para grass, sedge, and ragweed, which are very common in Thailand. In addition, the investigators will study about the cross-reactivity among these group of allergen.

NCT ID: NCT01685034 Withdrawn - Clinical trials for Eosinophilic Esophagitis

Allergy Immunotherapy in the Management of Eosinophilic Esophagitis

AIMEE
Start date: n/a
Phase: N/A
Study type: Interventional

Eosinophilic esophagitis (EoE) is a disease that has increased in incidence over the past decade that affects males predominantly, and in adults, is characterized by heartburn, dysphagia, strictures and food impactions. These symptoms may require emergent endoscopic removal of foods and esophageal dilations due to remodeling causing significant impairment in quality of life. Treatment options are limited and often not well tolerated or effective. There is poor understanding of the natural history and long term prognosis. It has been associated with allergic sensitization; a high percentage of affected individuals having associated atopy and current literature demonstrates a seasonal distribution of incidence and severity of symptoms. Allergy immunotherapy (AIT) is a well established and effective treatment for allergic rhinitis and asthma which can induce tolerance to environmental allergens. Given the efficacy of AIT and the association of aeroallergen sensitization and even seasonal variation of EoE symptoms, we hypothesized that AIT may be a treatment option for patients with EoE.

NCT ID: NCT01681615 Not yet recruiting - Clinical trials for Asthma, Aspirin-Induced

Challenge Test for Acetylsalicylic Acid Hypersensitivity

Start date: September 2012
Phase: N/A
Study type: Interventional

The investigators want to find new challenge test for Acetylsalicylic hypersensitivity / Aspirin hypersensitivity. The investigators suggest that this new test will be as efficient as the already established protocols in terms of sensitivity and specificity.

NCT ID: NCT01675882 Completed - Peanut Allergy Clinical Trials

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy

VIPES
Start date: August 2012
Phase: Phase 2
Study type: Interventional

The objectives of this dose-finding study for the treatment of peanut allergy are: - To determine the efficacy of 3 doses of Viaskin Peanut (50 mcg ,100 mcg and 250 mcg peanut protein per patch) to significantly desensitize peanut-allergic subjects to peanut after 12 months of treatment. - To evaluate the safety of a long-term treatment with Viaskin Peanut.

NCT ID: NCT01669785 Completed - Clinical trials for Tooth Hypersensitivity

NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study

Start date: March 2012
Phase: N/A
Study type: Interventional

The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.

NCT ID: NCT01667549 Completed - Development Clinical Trials

Sensitive Periods in Human Flavor Learning

Start date: August 2012
Phase: N/A
Study type: Interventional

The goals of the proposed research are to specify the timing and consequences of the sensitive period for flavor learning in infants who are being breastfed or formula fed. The investigators will conduct a randomized within- and between-subject study of women and their infants during a 15-month window.